Exact Mass: 565.3224

Exact Mass Matches: 565.3224

Found 374 metabolites which its exact mass value is equals to given mass value 565.3224, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

JSTX-3

Joro spider toxin

C27H47N7O6 (565.3588)

D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

Cinaciguat

4-{[(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)phenyl]methoxy}phenyl)ethyl]amino]methyl}benzoic acid

C36H39NO5 (565.2828)

2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-2-Amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]methylamino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetic acid

C30H39N5O6 (565.29)

N-Formyl-met-leu-phe-lys

6-amino-2-(2-{2-[2-formamido-4-(methylsulfanyl)butanamido]-4-methylpentanamido}-3-phenylpropanamido)hexanoic acid

C27H43N5O6S (565.2934)

Phe-Phe-Pro-Arg

2-{[(1-{2-[(2-amino-1-hydroxy-3-phenylpropylidene)amino]-3-phenylpropanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-5-carbamimidamidopentanoic acid

C29H39N7O5 (565.3013)

Tyr Ile Arg Asp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]butanedioic acid

C25H39N7O8 (565.286)

Leu Tyr Lys Glu

C27H43N5O8 (565.3111)

Phe Asp Thr Gly Leu

C26H39N5O9 (565.2748)

Val Tyr Arg Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]pentanedioic acid

C25H39N7O8 (565.286)

Leu Ser Ala Tyr Val

C27H43N5O8 (565.3111)

Thr Ala Phe Val Glu

C26H39N5O9 (565.2748)

Ser Leu Leu Ser Phe

C27H43N5O8 (565.3111)

TAFVE

Thr-Ala-Phe-Val-Glu

C26H39N5O9 (565.2748)

EAFSL

Glu Ala Phe Ser Leu

C26H39N5O9 (565.2748)

Antillatoxin B (red color)

C33H47N3O5 (565.3516)

Jawsamycin

C32H43N3O6 (565.3152)

A polyketide that is 5-amino-5-deoxy-3,4,5,6-tetrahydrouridine in which one of the hydrogens of the amino group is substituted by a (1E,3E)-1-[(1R,1R,1R,1R,2S,2R,2R,2S)-2-{(E)-2-[(1R,2R)-2-methylcyclopropyl]ethenyl}[1,1:2,1:2,1-quater(cyclopropan)]-2-yl]-5-oxopenta-1,3-dien-5-yl group. It is a metabolite isolated from the bacterium, Streptoverticillium fervens and targets the catalytic subunit of the fungal UDP-glycosyltransferase, the first step in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. It exhibits broad spectrum antifungal activity against several pathogenic fungi including Mucorales.

Fibrinogen-Binding Peptide

C25H39N7O8 (565.286)

Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin[1].

For-Met-Leu-Phe-Lys-OH

C27H43N5O6S (565.2934)

N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively[1].

Cinaciguat

C36H39NO5 (565.2828)

C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-2-Amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]methylamino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetic acid

C30H39N5O6 (565.29)

Joro spider toxin

ST 29:3;O3;Tau

C31H51NO6S (565.3437)

JNJ-31020028

C34H36FN5O2 (565.2853)

JNJ-31020028 is a selective and brain penetrant antagonist of neuropeptide Y Y2 receptor with pIC50 values of 8.07 and 8.22 for human and rat Y2 receptor, respectively. JNJ-31020028 can be used for the research of nervous disease[1].

MRTX-1257

C33H39N7O2 (565.3165)

MRTX-1257 is a selective, irreversible, covalent and orally active KRAS G12C inhibitor, with an IC50 of 900 pM for KRAS dependent ERK phosphorylation in H358 cells[1].

n-(5-{[3-({4-[(3-aminopropyl)amino]butyl}amino)-1-hydroxypropylidene]amino}pentyl)-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C27H47N7O6 (565.3588)

(2e,4e)-n-{[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1'r,2s)-2'-[(1'r,2r,2's)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1'r,2s)-2'-[(1'r,2r,2's)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

C32H43N3O6 (565.3152)

7'-(3,3-dimethyloxirane-2-carbonyl)-1-formyl-2'-hydroxy-1,6-dimethyl-3a-(methylamino)-4,6,7,8,9,9a,10,10a-octahydro-3h-spiro[cyclopenta[b]quinolizine-2,3'-indol]-8-yl butanoate

C32H43N3O6 (565.3152)

(2s)-2-(4-{2-[(1r,2e,4ar,4bs,8as,10as)-4b,8,8,10a-tetramethyl-2-[(sulfooxy)methylidene]-decahydrophenanthren-1-yl]ethyl}-2-oxo-5h-pyrrol-1-yl)-3-methylbutanoic acid

C30H47NO7S (565.3073)

(3s,6s,9s,16r,21as)-3-ethyl-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(2-methylpropyl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

(3s,6s,9s,16r,21as)-3-ethyl-1,10-dihydroxy-6-isopropyl-5,8,9-trimethyl-16-(2-methylpropyl)-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecane-4,7,14,17-tetrone

C28H47N5O7 (565.3475)

3-({3-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-5-(n-methylcarbamimidamido)pentylidene}amino)-6-[2-hydroxy-5-(hydroxymethyl)-4-iminopyrimidin-1-yl]-3,6-dihydro-2h-pyran-2-carboxylic acid

3-({3-[(2-amino-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-5-(n-methylcarbamimidamido)pentylidene}amino)-6-[2-hydroxy-5-(hydroxymethyl)-4-iminopyrimidin-1-yl]-3,6-dihydro-2h-pyran-2-carboxylic acid

C24H39N9O7 (565.2972)

(2e,4e)-n-{[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1s,1's,2r,2's)-2'-[(1s,1's,2s,2'r)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1s,1's,2r,2's)-2'-[(1s,1's,2s,2'r)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

C32H43N3O6 (565.3152)

5,11-dihydroxy-7,9,14-trimethyl-13-methylidene-6-(2-phenylethyl)-15-(4,6,6-trimethylhepta-2,4-dien-2-yl)-1-oxa-4,7,10-triazacyclopentadeca-4,10-diene-2,8-dione

C33H47N3O5 (565.3516)

(2e,4e)-n-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1r,1'r,2r,2's)-2'-[(1r,1's,2r,2'r)-2'-[(1z)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

{6-[5-(5-{[4-(acetyloxy)-1-hydroxypent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl)-3-methylpenta-1,3-dien-1-yl]-4-(ethoxymethyl)-4-hydroxyoxan-2-yl}acetic acid

C30H47NO9 (565.3251)

6'-ethenyl-7'-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-7-(1-methylpyrrolidin-2-yl)-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizine]-2,6-diol

C35H43N5O2 (565.3417)

(3r,6'r,7'r,8'as)-6'-ethenyl-7'-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-7-[(2r)-1-methylpyrrolidin-2-yl]-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizine]-2,6-diol

C35H43N5O2 (565.3417)